Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page
- ChecktodayChange DetectedRevision: v3.6.5 has been added to the study page to indicate the current version of the record. The Plain Language Summary and the earlier revision note v3.6.4 have been removed, altering how the study is presented to readers.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new release of the site's interface or tooling.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe page now shows a revision label updated from v3.6.0 to v3.6.3, indicating a recent update to the page framework. This change is an internal maintenance update and does not modify the study information presented.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now displays a recruitment-status note indicating that the study is no longer enrolling participants.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, reflecting a minor metadata update rather than substantive changes to study details.SummaryDifference0.0%

- Check85 days agoChange DetectedA new page revision tag, v3.5.4, was added and the previous v3.5.3 tag was removed, indicating a minor version update.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.